A pharmaceutical composition for use in treatment of Parkinson s disease is provided comprising a pharmaceutically acceptable carrier and a fixed dose combination of pramipexole and rasagiline wherein the fixed dose combination contains a subtherapeutic dose of pramipexole and a subtherapeutic dose of rasagiline and the dose of pramipexole is lower than or equal to the dose of rasagiline.